A Study of 177Lu-PSMA-617 in People With Gliomas

Clinical trial NCT07223034 · RECRUITING

Trial details

NCT number: NCT07223034
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Glioma Diffuse Astrocytoma, IDH-Wildtype (Grade 2-4)Glioblastoma, IDH-wildtype Diffuse Midline Glioma, H3 K27-Altered Diffuse Hemispheric Glioma, H3 G34-mutant Diffuse Pediatric-type High-grade Glioma, H3-wildtype and IDH-wildtype

Start date: 2025-10-27
Primary completion: 2027-10-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.